Atlassian Corp: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 5, 2023 and accepted by EDGAR at May 5, 2023, 20:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $915.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-07-01 to 2023-03-31 | $2.60bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-01 to 2023-03-31 | $168.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2022-07-01 to 2023-03-31 | $464.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-01-01 to 2023-03-31 | $746.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-07-01 to 2023-03-31 | $2.13bn | us-gaap:GrossProfit |
| Research and development | 3 months2023-01-01 to 2023-03-31 | $522.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-07-01 to 2023-03-31 | $1.40bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | −$161.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-07-01 to 2023-03-31 | −$294.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $8.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-07-01 to 2023-03-31 | $21.6m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $53.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-07-01 to 2023-03-31 | $162.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | −$209.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-07-01 to 2023-03-31 | −$427.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | −$0.81 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-07-01 to 2023-03-31 | −$1.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | −$0.81 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-07-01 to 2023-03-31 | −$1.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 256,825,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-07-01 to 2023-03-31 | 255,949,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-01 to 2023-03-31 | $352.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 9 months2022-07-01 to 2023-03-31 | $595.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-01 to 2023-03-31 | $2.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 9 months2022-07-01 to 2023-03-31 | $23.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2023-01-01 to 2023-03-31 | $31.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 9 months2022-07-01 to 2023-03-31 | $31.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-03-31 | $1.97bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $2.44bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $3.84bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $1.87bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $3.26bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $974.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-03-31 | $25.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-03-31 | $582.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001650372-23-000024. Last ingested by Listed: Nov 6, 2026, 16:44 ET. Listed shows no prices and gives no investment advice.